Histatin-5 vs Lixisenatide
Head-to-head comparison of Histatin-5 (Human histatin 5) and Lixisenatide (Exendin-4-derived GLP-1 receptor agonist) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Histatin-5 | Lixisenatide |
|---|---|---|
| Category | Dental & Oral | Weight Management |
| Full Name | Human histatin 5 | Exendin-4-derived GLP-1 receptor agonist |
| Molecular Weight | 3035 Da | 4858 Da |
| Half-Life | minutes in saliva | 2-4 hours |
| Amino Acids | 24 | 44 |
| Typical Dose | 1-100 µM in research formulations | 10-20 mcg daily |
| Route | Topical/Oral rinse | Subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 120 | 400 |
| Research Status | Pre-clinical | Approved |
Histatin-5 Benefits
- ✓anti-Candida activity
- ✓biofilm suppression
- ✓mucosal wound support
- ✓oral innate immunity
Lixisenatide Benefits
- ✓postprandial glucose control
- ✓modest weight loss
- ✓appetite reduction
- ✓short-acting option
Histatin-5 Dosing
topical rinse or gel|short contact exposure|repeat applications in research protocols
Lixisenatide Dosing
10 mcg SC daily for 14 days|Increase to 20 mcg daily|Inject before the first meal of the day
Histatin-5 Side Effects
- ⚠local irritation
- ⚠proteolytic instability
- ⚠dose-dependent cytotoxicity in vitro
Lixisenatide Side Effects
- ⚠nausea
- ⚠vomiting
- ⚠hypoglycemia when combined with insulin
Research Overview
Histatin-5
Histatin-5 is a major salivary defense peptide that can kill Candida species and influence oral microbial communities. It is also investigated for wound-healing and xerostomia-associated oral infection models.
Lixisenatide
Lixisenatide produces small but measurable weight loss in diabetes trials while improving postprandial glucose excursions. Its shorter half-life makes it a useful reference compound for first-generation incretin mimetics.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.